Improving enteral nutrition tolerance and protein intake maybe beneficial to intensive care unit patients.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

Original Publication: London : Nature Publishing Group, copyright 2011-

Enteral Nutrition*/adverse effects ; Critical Care*; Humans ; China ; Intensive Care Units ; Nutritional Status ; Critical Illness/therapy

Enteral nutrition (EN) is important for critically ill patients. This study investigated the current situation of EN treatment in SHANGHAI intensive care units (ICUs). We hypothesized that improving EN practice in SHANGHAI may benefit the prognosis of ICU patients. Clinical information on EN use was collected using clinic information forms in 2019. The collected data included the patient's general clinical information, EN prescription status, EN tolerance status, and clinical outcomes. The observation time points were days 1, 3, and 7 after starting EN. A total of 491 patients were included. The proportion of EN intolerance (defined as < 20 kcal/kg/day) decreased, with rates of intolerance of 100%, 82.07%, 70.61%, and 52.23% at 1, 3, 7, and 14 days, respectively. Age, mNutric score, and protein intake < 0.5 g/kg/day on day 7 were risk factors for 28-day mortality.The EN tolerance on day 7 and protein intake > 0.5 g/kg/day on day 3 or day 7 might affect the 28-day mortality. Risk factors with EN tolerance on day 7 by logistic regression showed that the AGI grade on day 1 was a major factor against EN tolerance. The proportion of EN tolerance in SHANGHAI ICU patients was low. Achieving tolerance on day 7 after the start of EN is a protective factor for 28-day survival. Improving EN tolerance and protein intake maybe beneficial for ICU patients.
(© 2023. The Author(s).)

Clin Nutr. 2019 Feb;38(1):48-79. (PMID: 30348463)
Curr Opin Crit Care. 2021 Aug 1;27(4):334-343. (PMID: 33990505)
JPEN J Parenter Enteral Nutr. 2018 Nov;42(8):1349-1357. (PMID: 29701877)
JAMA. 2012 Feb 22;307(8):795-803. (PMID: 22307571)
Crit Care Med. 2021 Jan 1;49(1):49-59. (PMID: 33148950)
Crit Care. 2022 Jan 21;26(1):24. (PMID: 35062981)
J Multidiscip Healthc. 2021 Feb 05;14:279-286. (PMID: 33574672)
Crit Care. 2021 Feb 27;25(1):88. (PMID: 33639997)
Crit Care. 2022 Feb 16;26(1):46. (PMID: 35172856)
Lancet. 2018 Jan 13;391(10116):133-143. (PMID: 29128300)
Saudi J Gastroenterol. 2022 Jan-Feb;28(1):1-2. (PMID: 35083976)
Clin Nutr. 2017 Jun;36(3):651-662. (PMID: 27373497)
Intensive Care Med. 2012 Mar;38(3):384-94. (PMID: 22310869)
Nutrition. 2012 Oct;28(10):1022-7. (PMID: 22673593)
Intensive Care Med. 2011 Apr;37(4):601-9. (PMID: 21340655)
Crit Care. 2011;15(6):R268. (PMID: 22085763)
Clin Nutr. 2017 Aug;36(4):1122-1129. (PMID: 27637833)
Crit Care. 2016 Nov 10;20(1):367. (PMID: 27832823)
Clin Nutr. 2021 Dec;40(12):5684-5709. (PMID: 34742138)
JPEN J Parenter Enteral Nutr. 2016 Feb;40(2):159-211. (PMID: 26773077)
Crit Care. 2018 Sep 24;22(1):229. (PMID: 30244686)
JPEN J Parenter Enteral Nutr. 2016 Jan;40(1):45-51. (PMID: 25900319)
Nutr Clin Pract. 2014 Jun;29(3):368-79. (PMID: 24740496)
Crit Care. 2021 Dec 14;25(1):424. (PMID: 34906215)
Nutr Clin Pract. 2017 Apr;32(1_suppl):6S-14S. (PMID: 28388376)
J Crit Care. 2015 Jun;30(3):473-5. (PMID: 25791768)
Clin Nutr. 2012 Aug;31(4):462-8. (PMID: 22209678)
N Engl J Med. 2015 Jun 18;372(25):2398-408. (PMID: 25992505)

SHD22021304 the Program for Outstanding Medical Academic Leaders and Clinical innovation Program in science and technology by Shengkang hospital development center

Date Created: 20231207 Date Completed: 20231216 Latest Revision: 20231222

20231222

PMC10703788

10.1038/s41598-023-49050-z

38062232